P1.14 Morbidity, Mortality and Oncologic Outcomes in Bronchoplastic Procedures Performed in a Mexican Public Reference Hospital

Abstract

months, HR 2.93 [95%CI 1.04-8.27 months], p ¼ 0.03). Conclusion: Thymic carcinoma constitutes an aggressive disease that is often diagnosed in advanced stages. These results suggest that multimodal treatment can be beneficial even in locally advanced cases. Larger clinical trial validating these conclusions are warranted.